Amal Therapeutics Competitors and Similar CompaniesClear all
Amal Therapeutics's competitors and similar companies include Alpha Tau Medical, NKGen Biotech, Zymeworks and Gossamer Bio.
 Amal Therapeutics Amal Therapeutics is a biotech company, which engages in the research and development of therapeutic vaccines in oncology. |  Alpha Tau Medical Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors. |  NKGen Biotech NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. | |
Founding Date | Founding Date N/A | Founding Date 2016 | Founding Date 2017 | Founding Date 2003 | Founding Date 2015 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Genève, CH HQ | Locations Tel Aviv-Yafo, IL HQ Boston, US | Locations Santa Ana, US HQ | Locations Vancouver, CA HQ Seattle, US | Locations San Diego, US HQ Dublin 2, IE |
Employees | Employees 254% decrease | Employees 1041% increase | Employees 7316% increase | Employees 45519% increase | Employees 11820% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 11 m | Valuation ($) 973.3 m | Valuation ($) 208 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $106m (FY, 2025) | Revenue (est.) $48.5m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($44.3m) (FY, 2024) | Net income ($81.1m) (FY, 2025) | Net income ($170.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 45.5m | Total funding raised $ 55m | Total funding raised $ 11m | Total funding raised $ 125.9m | Total funding raised $ 480m |
For sources of this data, please see the company profile
View Company Profiles
Alpha Tau Medical
HQ
Tel Aviv-Yafo, IL
Employees
104↑ 1% increase
Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors.
View companyNKGen Biotech
HQ
Santa Ana, US
Employees
73↑ 16% increase
NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells.
View companyZymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View companyGossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
View company